FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Attia

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Daniel J Powell; Peter Attia; Victor Ghetie; John Schindler; Ellen S Vitetta; STEVEN ROSENBERG
Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
Ajay V Maker; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Marybeth Hughes; Michael Yellin; Leah R Haworth; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Peter Attia; STEVEN ROSENBERG
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
Peter Attia; Daniel J Powell; Ajay V Maker; Robert J Kreitman; Ira Pastan; STEVEN ROSENBERG
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Attia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Daniel J Powell; Peter Attia; Victor Ghetie; John Schindler; Ellen S Vitetta; STEVEN ROSENBERG
Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(2):189-98.
2006: Ajay V Maker; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Marybeth Hughes; Michael Yellin; Leah R Haworth; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Peter Attia; STEVEN ROSENBERG
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(4):455-63.
2006: Peter Attia; Daniel J Powell; Ajay V Maker; Robert J Kreitman; Ira Pastan; STEVEN ROSENBERG
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):208-14.
2005: Ajay V Maker; Peter Attia; STEVEN ROSENBERG
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(11):7746-54.
2005: Ajay V Maker; Giao Q Phan; Peter Attia; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Leah R Haworth; Catherine Levy; David Kleiner; Sharon A Mavroukakis; Michael Yellin; STEVEN ROSENBERG
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
Annals of surgical oncology 2005;12(12):1005-16.
2005: Peter Attia; Ajay V Maker; Leah R Haworth; Linda Rogers-Freezer; STEVEN ROSENBERG
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(6):582-92.
2005: Peter Attia; Giao Q Phan; Ajay V Maker; Michael R Robinson; Martha Quezado; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Nicholas P Restifo; Leah R Haworth; Catherine Levy; Sharon A Mavroukakis; Geoffrey Nichol; Michael Yellin; STEVEN ROSENBERG
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6043-53.
2003: Peter Attia; Giao Q Phan; Paul H Duray; STEVEN ROSENBERG
Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.
American journal of clinical oncology 2003;26(1):42-5.
2001: Giao Q Phan; Peter Attia; Seth M Steinberg; Donald E White; STEVEN ROSENBERG
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3477-82.